Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
18.98
-0.59 (-3.01%)
Dec 20, 2024, 4:00 PM EST - Market closed

Pacira BioSciences Revenue

Pacira BioSciences had revenue of $168.57M in the quarter ending September 30, 2024, with 2.83% growth. This brings the company's revenue in the last twelve months to $694.96M, up 4.40% year-over-year. In the year 2023, Pacira BioSciences had annual revenue of $674.98M with 1.22% growth.

Revenue (ttm)
$694.96M
Revenue Growth
+4.40%
P/S Ratio
1.26
Revenue / Employee
$976,063
Employees
712
Market Cap
876.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023674.98M8.16M1.22%
Dec 31, 2022666.82M125.29M23.14%
Dec 31, 2021541.53M111.89M26.04%
Dec 31, 2020429.65M8.62M2.05%
Dec 31, 2019421.03M83.75M24.83%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AMN Healthcare Services 3.07B
Adaptive Biotechnologies 177.28M
Poseida Therapeutics 150.86M
Prothena Corporation 133.35M
Zymeworks 62.20M
Liquidia 15.61M
Revenue Rankings